Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

…, R Sobesky, M Martinot–Peignoux, S Maylin… - Gastroenterology, 2008 - Elsevier
BACKGROUND & AIMS: Our study was designed to test the association between insulin
resistance (IR) and hepatitis C virus (HCV) genotypes using serum HCV RNA level and liver …

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis

…, N Boyer, T Asselah, M Martinot-Peignoux, S Maylin… - Journal of …, 2010 - Elsevier
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) currently represents the major
cause of liver-related death in patients with hepatitis C virus (HCV)-related cirrhosis. We …

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C

S Maylin, M Martinot–Peignoux, R Moucari, N Boyer… - Gastroenterology, 2008 - Elsevier
Background & Aims: It is unclear whether hepatitis C virus (HCV) is eradicated in patients
with chronic hepatitis C who achieved a sustained virologic response (SVR). Methods: In this …

[PDF][PDF] Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: relevance of quantitative RT‐PCR for follow‐up

…, N Boyer, BN Pham, S Maylin… - …, 2006 - Wiley Online Library
Hepatitis delta virus (HDV) can cause severe acute and chronic liver disease in patients
infected by hepatitis B virus. Interferon alpha at high doses, although poorly efficient, is the only …

[PDF][PDF] Twelve weeks posttreatment follow‐up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving …

M Martinot‐Peignoux, C Stern, S Maylin… - …, 2010 - Wiley Online Library
A sustained virologic response (SVR) in patients with chronic hepatitis C receiving pegylated
interferon (PEG‐IFN) plus ribavirin is defined as undetectable serum HCV‐RNA at 24 …

Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients

A Boyd, K Lacombe, F Lavocat, S Maylin, P Miailhes… - Journal of …, 2016 - Elsevier
Background & Aims In the presence of highly-potent antivirals, persistence of hepatitis B
virus (HBV) is most well-characterized by covalently-closed circular DNA (cccDNA) and total …

Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real‐life

…, N Boyer, N Giuly, A Gerber, I Tout, S Maylin… - Liver …, 2021 - Wiley Online Library
Hepatitis delta virus (HDV) infection is the most severe form of viral hepatitis. Bulevirtide (BLV,
Hepcludex ® ) is an HDV/HBV entry inhibitor approved in June 2020 in the European …

[PDF][PDF] Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long‐term tenofovir: virological and clinical implications

A Boyd, J Gozlan, S Maylin, C Delaugerre… - …, 2014 - Wiley Online Library
Tenofovir (TDF) is considered the ideal treatment for patients coinfected with human
immunodeficiency virus (HIV) and hepatitis B virus (HBV). However, certain coinfected patients …

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin

M Martinot-Peignoux, S Maylin, R Moucari… - Antiviral …, 2009 - journals.sagepub.com
Background Viral kinetics during therapy provides information on how to individualize
treatment. To determine the benefit of assessing positive predictive values (PPVs) and negative …

Hepatitis B virus‐hepatitis D virus mother‐to‐child co‐transmission: a retrospective study in a developed country

PO Sellier, S Maylin, S Brichler, B Berçot… - Liver …, 2018 - Wiley Online Library
Background & Aims Hepatitis B Virus ( HBV ) DNA during chronic infection can reach levels
at which mother‐to‐child ( MTC ) transmission frequently occurs despite passive‐active …